29. Overview of Consolidation Scope
The parent company argenx SE is domiciled in the Netherlands. The Company, argenx SE, has one subsidiary, argenx BV, which is based in Belgium. argenx BV has sixteen subsidiaries. Details of the Company’s consolidated entities at the end of the reporting period are as follows:
Name |
|
Country |
|
Participation |
|---|---|---|---|---|
argenx SE |
|
the Netherlands |
|
100% |
argenx B.V. |
|
Belgium |
|
100% |
argenx Benelux B.V. |
|
Belgium |
|
100% |
argenx US, Inc. |
|
USA |
|
100% |
argenx Australia Pty. Ltd. |
|
Australia |
|
100% |
argenx Austria Services GmbH |
|
Austria |
|
100% |
argenx Brasil Produtos Farmacêuticos Ltda |
|
Brazil |
|
100% |
argenx Canada Inc. |
|
Canada |
|
100% |
argenx France SAS |
|
France |
|
100% |
argenx Germany GmbH |
|
Germany |
|
100% |
argenx Italy S.r.l. |
|
Italy |
|
100% |
argenx Japan KK. |
|
Japan |
|
100% |
argenx Netherlands Services B.V. |
|
the Netherlands |
|
100% |
argenx Spain S.L. |
|
Spain |
|
100% |
argenx Spain S.L. – Sucursal em Portugal |
|
Portugal |
|
100% |
argenx Switzerland, S.A. |
|
Switzerland |
|
100% |
argenx UK Ltd. |
|
United Kingdom |
|
100% |
Broteio Pharma B.V. |
|
the Netherlands |
|
100% |